Summary & Overview
HCPCS C7553: Coronary Catheterization with Graft Angiography and Hemodynamic Assessment
HCPCS Level II code C7553 represents comprehensive coronary catheterization services that combine coronary angiography, right and left heart catheterization, bypass graft angiography, and pharmacologic agent administration with hemodynamic assessment. This code captures a complex diagnostic and physiologic evaluation used in coronary artery disease assessment and perioperative graft evaluation. Nationally, C7553 matters because it denotes a high-acuity cardiac diagnostic procedure often performed in catheterization laboratories and impacts hospital billing, resource allocation, and quality measurement for invasive cardiac evaluation.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical scope and service setting, payer coverage patterns and common billing modifiers, and benchmarks for utilization where available. The publication also summarizes policy considerations affecting coding and billing for combined angiography and hemodynamic testing, and provides clinical context to assist coding accuracy.
The report is intended for coding managers, hospital billing teams, and clinical leaders seeking concise guidance on the service components represented by C7553, typical sites of care, and what to expect from major national payers. Data not available in the input will be noted explicitly in relevant sections.
Billing Code Overview
HCPCS Level II code C7553 describes catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation. The code also includes right and left heart catheterization with intraprocedural injection(s) for left ventriculography when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography, and administration of pharmacologic agents (for example, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessment of hemodynamic measurements before, during, after and repeat pharmacologic agent administration when performed.
Service type: Diagnostic and interventional coronary catheterization with hemodynamic assessment and pharmacologic provocation
Typical site of service: Cardiac catheterization laboratory or interventional cardiology suite, with imaging performed in the inpatient or outpatient hospital setting or ambulatory surgical center depending on clinical context.
Clinical & Coding Specifications
Clinical Context
A 68-year-old man with progressive exertional chest pain, known history of coronary artery disease with prior coronary artery bypass grafting (CABG), hypertension, and preserved left ventricular function is admitted for evaluation of suspected ischemia. Noninvasive testing demonstrates inducible ischemia in the anterior and lateral walls. The interventional cardiology team schedules an invasive diagnostic procedure: catheter placement in coronary artery(s) for coronary angiography with right and left heart catheterization, selective catheterization and angiography of native coronaries and bypass grafts (internal mammary and saphenous vein grafts), and left ventriculography. During the procedure, pharmacologic agents (for example, intravenous nitroprusside and dobutamine) are administered to assess hemodynamics and provoke or treat ischemia while intracardiac and systemic pressures are measured before, during, and after administration.
Workflow:
-
Patient evaluated in pre-procedure area; informed consent and review of indications, anticoagulation status, and allergies completed.
-
Local vascular access achieved (commonly femoral or radial artery) and arterial sheath placed.
-
Diagnostic coronary guide catheters advanced for selective coronary angiography; contrast injections performed with fluoroscopic imaging; grafts are selectively catheterized and imaged if prior CABG present.
-
Right heart catheterization performed via venous access when indicated to measure pulmonary artery pressures and cardiac output.
-
Left ventriculography performed during left-sided catheterization if indicated to assess LV function.
-
Pharmacologic agents administered intravenously or inhaled as indicated (eg, vasodilators, inotropes) with serial hemodynamic measurements recorded before, during, and after dosing.